Top Midday Gainers

MT Newswires Live

5 hours ago

Viatris (VTRS) agreed to acquire Pacira BioSciences (PCRX) in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday.

Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000.

Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027.

Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000.

UBS adjusted its price target on XP (XP) to $37 from $25 while keeping its buy rating for the stock.

XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million.

Price: 17.35, Change: -0.14, Percent Change: -0.80

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2674002893"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2674002893\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2674002893?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-09 02:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2674002893","market":"us","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Viatris (VTRS) agreed to acquire Pacira BioSciences (PCRX) in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday.</p><p>Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000.</p><p>Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027.</p><p>Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000.</p><p>UBS adjusted its price target on XP (XP) to $37 from $25 while keeping its buy rating for the stock.</p><p>XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million.</p><p>Price: 17.35, Change: -0.14, Percent Change: -0.80</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-10-09 02:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Viatris (VTRS) agreed to acquire Pacira BioSciences (PCRX) in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday.</p><p>Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000.</p><p>Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027.</p><p>Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000.</p><p>UBS adjusted its price target on XP (XP) to $37 from $25 while keeping its buy rating for the stock.</p><p>XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million.</p><p>Price: 17.35, Change: -0.14, Percent Change: -0.80</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0788109048.HKD","symbol_name":"BGF LATIN AMERICAN \"A2\" (HKDHGD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2674002893","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2674002893","pubTimestamp":1791484201,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Viatris  agreed to acquire Pacira BioSciences  in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday.Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000.Haemonetics  said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027.Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000.UBS adjusted its price target on XP  to $37 from $25 while keeping its buy rating for the stock.XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million.Price: 17.35, Change: -0.14, Percent Change: -0.80","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0788109048.HKD":"BGF LATIN AMERICAN \"A2\" (HKDHGD) ACC","IE0034390439.USD":"FTGF ROYCE US SMALLER COMPANIES \"A\" (USD) D","LU0047713382.USD":"BGF EMERGING MARKETS \"A2\" ACC","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","BK4007":"制药","LU1861217088.USD":"贝莱德金融科技A2","LU1051769294.HKD":"BGF EMERGING MARKETS EQUITY INCOME \"A6\"(HKDHDG) INC","XP":"XP Inc.","BK4583":"猴痘概念","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU1861220207.SGD":"Blackrock FinTech A2 SGD-H","VTRS":"Viatris Inc.","LU1051768304.USD":"贝莱德新兴市场股票收益A6","HAE":"美国血液技术","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","IE00B19Z6F94.USD":"Legg Mason Royce - US Smaller Companies A Acc USD","BK4585":"ETF&股票定投概念","BK4198":"医疗保健用品","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","LU0572108347.SGD":"Blackrock Latin American A2 SGD-H","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","PCRX":"Pacira Pharmaceuticals","BK4127":"投资银行业与经纪业","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","LU0050427557.USD":"富达拉丁美洲基金","LU0196696453.USD":"HSBC GIF BRAZIL EQUITY \"AC\" (USD) ACC","LU0531971322.HKD":"HSBC GIF BRAZIL EQUITY \"AD\" (HKD) INC","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","LU0072463663.USD":"Blackrock Latin American A2 USD","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU0196696701.USD":"HSBC GIF BRAZIL EQUITY \"AD\" (USD) INC","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","BK4588":"碎股","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC"},"translate_title":"午盘涨幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":1,"XP":1,"HAE":1,"VTRS":1},"content_text":"Viatris (VTRS) agreed to acquire Pacira BioSciences (PCRX) in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday.Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000.Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027.Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000.UBS adjusted its price target on XP (XP) to $37 from $25 while keeping its buy rating for the stock.XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million.Price: 17.35, Change: -0.14, Percent Change: -0.80","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}